Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis

C. R. Roth, L. E. Glaze, Jr Goding, W. S. David

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

A patient initially diagnosed with adductor-type spasmodic dysphonia was referred for botulinum toxin (Botox) injections, but found on subsequent evaluation to have amyotrophic lateral sclerosis, and therefore Botox was not administered. This unique case underscores the need to delay botulinum toxin treatments in any patient with recent onset symptoms, and to obtain thorough motor speech and voice, otolaryngologic, and neurologic evaluation in all patients prior to consideration for injection.

Original languageEnglish (US)
Pages (from-to)362-367
Number of pages6
JournalJournal of Voice
Volume10
Issue number4
DOIs
StatePublished - Jan 1 1996

Keywords

  • Amyotrophic lateral sclerosis
  • Botulinum toxin
  • Spasmodic dysphonia

Fingerprint Dive into the research topics of 'Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Cite this